SLC7A11 and familial pancreatic carcinoma: When SLC7A11 was downregulation or inactivation, genetically or pharmacologically, shown to potently induce lipid peroxidation and ferroptosis in pancreatic cancer cells, led to proliferation arrest and cell death, suggesting great potential as a strategy for anticancer therapy [39, 40].